The pharmaceutical landscape experiencing a revolution with the emergence of novel glucagon-like peptide-1 (GLP-1) receptor agonists. These innovative drugs demonstrate immense potential in managing type 2 diabetes https://darrenzfif069567.blgwiki.com/1614762/novel_glp_1_receptor_agonists_retatrutide_cagrillintide_tirzepatide_and_semaglutide